Robin Levis U.S. FDA

Dr. Robin Levis has worked at the US Food and Drug Administration since 1995. She is currently the Deputy Director of the Division of Viral Products in the Office of Vaccines Research and Review at CBER/FDA. Prior to this position, she served as the Regulatory Coordinator for the Division of Viral Products and as a Senior Staff Fellow in the Laboratory of Vector Borne Viral Diseases. In addition to her work in the Office of Vaccines at CBER, she has served as the CBER representative to ICCVAM, as an observer to EDQM Group 15 for vaccines, a member of the WHO/NC3Rs working group, and serves on several vaccine working groups for the Coalition for Epidemic Preparedness Innovations. Her role on these International working groups is to encourage global regulatory harmonization and to provide regulatory support related to CMC development and product quality for viral vaccines and to the development of alternative, non-animal-based quality assays.